High levels of anxiety in patients receiving wet AMD treatment
Research conducted at Manchester Royal Eye Hospital has revealed high levels of undiagnosed depression and anxiety among patients undergoing treatment for wet age-related macular degeneration (AMD). The main sources of anxiety were fear of going blind from the injections and concerns about treatment effectiveness, rather than trepidation around pain.
The report has highlighted the need for better communication between patients and doctors so that fears can be addressed. For more information about the research, visit the Macular Society website
Posted on the 24th of April 2017